Stay updated on Olaptesed with Pembrolizumab in Colorectal and Pancreatic Clinical Trial
Sign up to get notified when there's something new on the Olaptesed with Pembrolizumab in Colorectal and Pancreatic Clinical Trial page.

Latest updates to the Olaptesed with Pembrolizumab in Colorectal and Pancreatic Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page header revision label was updated from v3.4.1 to v3.4.2 (v3.4.1 removed).SummaryDifference0.1%

- Check28 days agoChange DetectedThe page now displays Revision: v3.4.1, replacing the previous Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check35 days agoChange DetectedAdded a glossary display option, the 'Last Update Submitted that Met QC Criteria' entry, the 'No FEAR Act Data' section, and a 'Revision: v3.4.0' note. Removed the older 'Last Update Submitted that met QC Criteria' entry, the 'No FEAR Act data' label, and the 'Revision: v3.3.4' note.SummaryDifference0.2%

- Check50 days agoChange DetectedThe page now shows revision tag v3.3.4 replacing v3.3.3; this is a metadata update and does not affect study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check71 days agoChange DetectedFooter updates include adding Revision: v3.3.3 and removing HHS Vulnerability Disclosure and Revision: v3.3.2.SummaryDifference0.1%

- Check100 days agoChange DetectedThe page revision updated from v3.2.0 to v3.3.2, reflecting a minor label change with no impact on study data or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Olaptesed with Pembrolizumab in Colorectal and Pancreatic Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Olaptesed with Pembrolizumab in Colorectal and Pancreatic Clinical Trial page.